NMPA Approval

Recombinant Ebola Virus Disease Vaccine (Adenovirus Type 5 Vector)

Approval Number

国药准字S20170008

Company康希诺生物股份公司

Registration Date

October 13, 2022

Previous Approval Numbers

国药准字S20170008

Drug Information

Generic Name

重组埃博拉病毒病疫苗(腺病毒载体)

Dosage Form

注射剂

Strength

复溶后每瓶0.5ml，每1次人用剂量2瓶，共1ml，含表达埃博拉病毒包膜糖蛋白的重组复制缺陷型人5型腺病毒8×10^10VP。

Drug Type

生物制品

Registration Date

October 13, 2022

Company Information

Applicant Company

Company Name康希诺生物股份公司

Company Address

天津经济技术开发区西区南大街185号西区生物医药园四层401-420号

Manufacturing Company

Company Name康希诺生物股份公司

Company Address

天津经济技术开发区西区南大街185号西区生物医药园三层

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

重组埃博拉病毒病疫苗(腺病毒载体) - NMPA 批准文号 | MedPath